General Inception

www.generalinception.com

VCMatch tracks General Inception as an investor focused on Biotech, Medtech, and Healthtech companies, Pre-Seed and Seed rounds, and United States, Europe, and France markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed, Series A, Series B, Growth

Focus Areas

Biotech, Medtech, Healthtech

Geography

United States, Europe, and France

Investment Thesis

General Inception operates as a ‘Deep Tech Venture studio’ that partners with extraordinary technical co-founders to solve fundamental problems in science-based company creation. Rather than traditional venture capital, they position themselves as ‘your business co-founder,’ providing the right people, customers, and funding access to start and scale successful companies. Their core model emphasizes bringing the right people together at the right time for successful company formation and growth, with the GI team taking on most day-to-day planning and execution activities.

Is General Inception right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

General Inception is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Biotech, Medtech, Healthtech, and Hardware, especially across United States, Europe, and France.

Focus statement

General Inception focuses on deep tech and life sciences companies spanning engineered biology, life science tools & diagnostics, and therapeutics. They specialize in translating deep tech visions to customers through hands-on company building from inception through seed investment and beyond.

Value Add

Full-service venture studio model with hands-on operational involvement in portfolio companies
Team with centuries of combined life science operating experience, including former Flagship, McKinsey, and biotech leaders
Access to interconnected portfolio ecosystem for sharing technologies, customers, and markets
Four-phase repeatable model: Ignite, Nurture, Scale, Repeat
Fractional services business extending capabilities beyond portfolio (Transformation Services, Fractional Finance, Lab Services)
European expansion through Igniter Europe leveraging local scientific talent across France, Belgium, Netherlands, and UK
GIL'S (General Inception Lab Services) providing validation and assay expertise in fibrosis, oncology, inflammation, and autoimmune diseases